Blue Bird Corp. (BLBD)

NASDAQIndustrialsAuto - ManufacturersSnapshot 2026-10-23

$57.73+1.76%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Blue Bird Corp.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
FY 2027 · Q1
Revenue	—	449.37M
EPS	—	0.958
FY 2026 · Annual
Revenue	About $1.75B	—
EBITDA	About $247M	—
FY 2027 · Annual
Revenue	—	2.01B
EPS	—	4.441
FY 2028 · Annual
Revenue	—	2.24B
EPS	—	5.502

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Free cash flow improves next quarter	Free cash flow is expected to improve.	Improving	Free cash flow falls or stays negative next quarter	Free cash flow: $21.661M FY2026-Q3; GAAP. Published target: positive or improving. The target does not explicitly identify fiscal versus calendar quarters. Source published Aug 5, 202621,661,000 USD · calculatedSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q3 · Period ending Jun 27, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q3. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Gross margin at least 15% next quarter	Profit margin should be at least 15%.	Intact	Gross margin falls below 15% next quarter	Gross margin: 19.99% FY2026-Q3; GAAP. Published target: >=15 PERCENT. Target percentage unit is not explicit. Source published Aug 5, 202619.988785 percent · calculatedSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q3 · Period ending Jun 27, 2026 Source: company_financial_results. Reference: 6adb8f8d-4a46-4e63-b7e8-2d382926c670. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Management delivers on growth and margin targets	A supporting condition in Blue Bird Corp.'s published investment case. The stated target is consistent progress toward $2.5B revenue and 15% margin.	Improving	Management fails to make steady progress on targets	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Revenue of at least $1.75 billion next quarter	Blue Bird aims for $1.75 billion revenue next quarter.	Intact	Revenue falls below $1.45 billion next quarter	Revenue: $517.16M FY2026-Q3; GAAP. Published target: >=1750 USD_MILLIONS. The target does not explicitly identify fiscal versus calendar quarters. Source published Aug 5, 2026517,160,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q3 · Period ending Jun 27, 2026 Source: company_financial_results. Reference: 6adb8f8d-4a46-4e63-b7e8-2d382926c670. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2028 · fiscal year ending 2028-09-27 · fmp

FY2028 EPS: comparable history unavailable.

FY2028 revenue: comparable history unavailable.

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2028 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-09-28	Unavailable	Unavailable	2 / 2
2026-09-29	Unavailable	Unavailable	2 / 2
2026-09-30	Unavailable	Unavailable	2 / 2
2026-10-01	Unavailable	Unavailable	2 / 2
2026-10-02	Unavailable	Unavailable	2 / 2
2026-10-03	Unavailable	Unavailable	3 / 3
2026-10-04	Unavailable	Unavailable	3 / 3
2026-10-05	Unavailable	Unavailable	3 / 3
2026-10-06	Unavailable	Unavailable	3 / 3
2026-10-07	Unavailable	Unavailable	3 / 3
2026-10-08	Unavailable	Unavailable	3 / 3
2026-10-09	Unavailable	Unavailable	3 / 3
2026-10-10	Unavailable	Unavailable	3 / 3
2026-10-11	Unavailable	Unavailable	3 / 3
2026-10-12	Unavailable	Unavailable	3 / 3
2026-10-13	Unavailable	Unavailable	3 / 3
2026-10-14	Unavailable	Unavailable	3 / 3
2026-10-15	Unavailable	Unavailable	3 / 3
2026-10-16	Unavailable	Unavailable	3 / 3
2026-10-17	Unavailable	Unavailable	3 / 3
2026-10-18	Unavailable	Unavailable	3 / 3
2026-10-19	Unavailable	Unavailable	3 / 3
2026-10-20	Unavailable	Unavailable	3 / 3
2026-10-21	Unavailable	Unavailable	3 / 3
2026-10-22	Unavailable	Unavailable	3 / 3
2026-10-23	Unavailable	Unavailable	3 / 3
2026-10-24	Unavailable	Unavailable	3 / 3

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	7	1
2026-06-01	7	1
2026-07-01	7	1
2026-08-01	8	1
2026-09-01	8	0
2026-10-01	8	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 8 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Free cash flow improves next quarterFree cash flow: $21.661M
Gross margin at least 15% next quarterGross margin: 19.99%
Management delivers on growth and margin targetsDirect metric needs a verified mapping
Revenue of at least $1.75 billion next quarterRevenue: $517.16M

Next proof point

Nov 23, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.3%Typical daily move · historical

Downside history

-31.9%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Blue Bird Corp. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is an execution-led industrial growth story, with recent financial performance rated strong and valuation described as cheap versus peers. The multi-year view is intact, though the signal has softened from favorable to mildly favorable and management is rated volatile.

What's priced into Blue Bird Corp.

The evidence describes BLBD as cheap versus peers, with the expectations gap pointing below the model’s implied expectations. The priced-in assessment is tagged justified, and fragility is low, so the valuation evidence does not suggest that the thesis depends on unusually high expectations.

What the fundamentals likely do

Near term, revenue growth and raised 2026 guidance support the company’s stated financial goals: revenue rose from $333 million in Q1 to $517 million in Q3, while adjusted EBITDA guidance increased to $247 million. Alternative-powered bus deliveries continue, but firm EV orders eased from over 900 to 770, and the sector backdrop is a headwind; recent guidance cuts would also damage management credibility.

What Blue Bird Corp. hinges on

The main swing factor is whether BLBD sustains execution after raising guidance, rather than reversing course with a cut. Over the near term, XOS earnings and guidance may signal whether the broader industrial-sector support strengthens or fades. The longer-term case also depends on progress toward the stated $2.5 billion revenue goal and continued delivery on alternative-powered buses.